알림마당

국민건강보호를 위한 공공 백신 확보 및 안정적인 백신 수급 체계를 구축할 수 있도록 최선을 다하겠습니다.

언론 · 보도자료

제목 언론보도 [아리랑TV] Innovation in response to COVID-19: 2021 Bio Korea convention 210611
  • 작성자 관리자
  • 작성일 2021-06-11
  • 조회수 413
첨부파일

"The 2021 Biokorea conference held in Seoul displays some of the most impressive milestones reached by the country’s leading bio firms and researchers."

Most notable at the convention were innovations related to COVID-19.
The researchers' work displayed at the event shows their efforts to improve the process of battling the disease, from virus prevention to diagnosis.

"BIOT have developed a robot that medical workers can use during COVID-19 testing to extract specimens from the testees without any contact. It diminishes the risk of infection, lessens the pain of testing, and is much more affordable than competing products."

New technology could give South Korea the ability to spearhead vaccine development in a potential future pandemic,.. with the government directing funds to the long-term research of domestic vaccines.
And at the head of that research is Professor Seong Baik-lin.

"Rapid production technology needs continued development. We need to start getting ready now to develop this technology so that South Korea comes out as a front-runner ready for another pandemic that might come in the future."

What he and his team are working through the weekends trying to achieve is creating a game-changing platform that speeds up the development process of safe and effective synthetic vaccines.

"Behind the AstraZeneca vaccines, there were 230 years of research that can be traced back to Edward Jenner's small pox vaccines. We can't put in 200 years, but what are we Koreans good at? Shortening and speeding up the process. I think building this platform will be possible in 20 years."
 

 

방송 바로보기

 

 

이전글 [중앙일보] K-바이오 랩허브 유치를 위해 산학연병 라운드 테이블 열려 210607
다음글 [ZD net Korea] "백신 개발 연구 기간 단축하는 게 바이오 경쟁력 관건" 210610